Breaking News Instant updates and real-time market news.

LPCN

Lipocine

$1.63

0.02 (1.24%)

04:55
02/08/19
02/08
04:55
02/08/19
04:55

Lipocine management to meet with Oppenheimer

Meetings to be held in New York on February 7 and in Boston on February 8 hosted by Oppenheimer.

  • 08

    Feb

  • 21

    Feb

LPCN Lipocine
$1.63

0.02 (1.24%)

01/17/19
LTCO
01/17/19
NO CHANGE
Target $5
LTCO
Buy
Ladenburg reiterates Buy rating, $5 price target on Lipocine after NASH data
Ladenburg analyst Matthew Kaplan reiterates his Buy rating and $5 price target on shares of Lipocine after the company announced interim results from the ongoing 16-week liver fat imaging study with LPCN 1144. He said he is encouraged by these preliminary, 8-week results, which show a rapid reduction in liver fat levels from baseline based on MRI assessment, and looks forward to the full study results later this year. Kaplan also noted that Lipocine is working to resolve the four issues detailed in the CRL received in May 2018 and he expects results from the "rate-limiting" AMB BP study in late Q1.
01/17/19
RILY
01/17/19
NO CHANGE
Target $16
RILY
Buy
Viking selloff on Citron's Ligand report overdone, says B. Riley FBR
B. Riley FBR analyst Mayank Mamtani views the selloff yesterday in shares of Viking Therapeutics (VKTX) after Citron Research published a short report on Ligand Pharmaceuticals (LGND), the company's largest shareholder, as overdone. Interestingly, Ligand values Viking at a 10 times higher valuation than current trading levels, Mamtani tells investors in a research note. The analyst, whose firm does not cover Ligand, believes the report supports his thesis of Viking being an undervalued nonalcoholic steatohepatitis story. Additionally, competitor Lipocine's (LPCN) fat reduction data this morning, "while surprisingly positive," fell short of meeting/exceeding the 10.6% absolute fat reduction data reported from Viking in a Phase IIa study of early NASH patients, says Mamtani. He believes Viking Therapeutics maintains its "best in class status" and reiterates a Buy rating on the shares with a $16 price target. The stock in atfernoon trading is up 4%, or 35c, to $8.35.
01/17/19
LTCO
01/17/19
NO CHANGE
Target $5
LTCO
Buy
Ladenburg reiterates Buy rating, $5 price target on Lipocine after NASH data
Ladenburg analyst Matthew Kaplan reiterates his Buy rating and $5 price target on shares of Lipocine after the company announced interim results from the ongoing 16-week liver fat imaging study with LPCN 1144. He said he is encouraged by these preliminary, 8-week results, which show a rapid reduction in liver fat levels from baseline based on MRI assessment, and looks forward to the full study results later this year. Kaplan also noted that Lipocine is working to resolve the four issues detailed in the CRL received in May 2018 and he expects results from the "rate-limiting" AMB BP study in late Q1.
01/18/19
HCWC
01/18/19
NO CHANGE
Target $3
HCWC
Buy
Lipocine liver fat reduction data 'surprisingly strong,' says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat says Lipocine yesterday reported "surprisingly strong" liver fat reduction interim data. The analyst reiterates a Buy rating on the shares with a $3 price target. The LPCN-1144 results could justify proceeding to a biopsy confirmed Phase 2a non-alcoholic steatohepatitis trial and inclusion of something for NASH in our valuation, Livnat tells investors in a research note.

TODAY'S FREE FLY STORIES

UUGRY

United Utilities

$0.00

(0.00%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Upgrade
United Utilities rating change  »

United Utilities upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$8.54

-0.16 (-1.84%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Hot Stocks
La Jolla treatment of malaria granted FDA orphan status »

La Jolla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$22.78

-0.01 (-0.04%)

07:09
07/23/19
07/23
07:09
07/23/19
07:09
Hot Stocks
Interpublic Group remains on track to deliver 2%-3% organic growth »

Michael Roth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 08

    Aug

UTX

United Technologies

$132.94

0.57 (0.43%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Hot Stocks
Breaking Hot Stocks news story on United Technologies »

United Technologies up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NGG

National Grid

$51.92

-0.02 (-0.04%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Upgrade
National Grid rating change  »

National Grid upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

IRDM

Iridium

$24.15

0.43 (1.81%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Hot Stocks
Iridium sees FY19 service revenue $440M »

Sees FY19 OEBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

IPG

Interpublic Group

$22.78

-0.01 (-0.04%)

07:08
07/23/19
07/23
07:08
07/23/19
07:08
Earnings
Interpublic Group reports Q2 adjusted EPS 46c, consensus 44c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 08

    Aug

REAL

RealReal

$24.84

0.69 (2.86%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Initiation
RealReal initiated  »

RealReal initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

PNR

Pentair

$37.59

0.21 (0.56%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Earnings
Pentair sees Q3 adjusted EPS 54c-56c, consensus 55c »

The company expects third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ENGIY

Engie SA

$0.00

(0.00%)

07:07
07/23/19
07/23
07:07
07/23/19
07:07
Upgrade
Engie SA rating change  »

Engie SA upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRDM

Iridium

$24.15

0.43 (1.81%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Iridium reports Q2 EPS (16c), consensus (19c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PNR

Pentair

$37.59

0.21 (0.56%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Pentair updates FY19 adjusted EPS view to approx. $2.35 from $2.30-$2.35 »

Consensus is $2.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ZION

Zions Bancorp

$45.16

-0.95 (-2.06%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Recommendations
Zions Bancorp analyst commentary  »

Zions Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBCP

Home Bancorp

$36.17

0.39 (1.09%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Home Bancorp reports Q2 EPS 71c, consensus 76c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTE

Astec

$31.16

0.38 (1.23%)

, VMI

Valmont

$127.99

-1.03 (-0.80%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Hot Stocks
Astec appoints Barry Ruffalo as president, CEO »

Astec Industries(ASTE) …

ASTE

Astec

$31.16

0.38 (1.23%)

VMI

Valmont

$127.99

-1.03 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

UTX

United Technologies

$132.94

0.57 (0.43%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Earnings
United Technologies raises FY19 adj. EPS view to $7.90-$8.05 from $7.80-$8.00 »

Consensus $7.97. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DNNGY

Orsted A/S

$0.00

(0.00%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Downgrade
Orsted A/S rating change  »

Orsted A/S downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Earnings
Sherwin-Williams reaffirms FY19 adj. EPS view $20.40-$21.40, consensus $20.94 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 06

    Aug

07:05
07/23/19
07/23
07:05
07/23/19
07:05
General news
FX Update: The dollar has posted fresh highs »

FX Update: The dollar has…

JBLU

JetBlue

$18.96

0.05 (0.26%)

, EADSY

Airbus

$0.00

(0.00%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Earnings
JetBlue sees achieving $2.50-$3.00 EPS target for 2020, consensus $2.39 »

JetBlue CEO Robin Hayes…

JBLU

JetBlue

$18.96

0.05 (0.26%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 31

    Jul

TXRH

Texas Roadhouse

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Initiation
Texas Roadhouse initiated  »

Texas Roadhouse initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

SZEVY

Suez

$0.00

(0.00%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Downgrade
Suez rating change  »

Suez downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Hot Stocks
Coca-Cola sees FY19 cash from operations at least $8.5B »

Sees FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

ASTE

Astec

$31.16

0.38 (1.23%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Earnings
Astec reports Q2 adjusted EPS 36c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBLU

JetBlue

$18.96

0.05 (0.26%)

07:03
07/23/19
07/23
07:03
07/23/19
07:03
Hot Stocks
JetBlue sees FY19 capacity up 5.5%-6.5% »

For the full year 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.